药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02359 药明康德

休市中 12-24 12:08:24

99.150

+0.100

+0.10%

最高101.200	最低99.000	成交量137.26万
今开99.000	昨收99.050	日振幅2.22%
总市值2,959亿	流通市值506.14亿	总股本29.84亿
成交额1.37亿	换手率0.27%	流通股本5.10亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02359","market":"HK","secType":"STK","nameCN":"药明康德","latestPrice":99.15,"timestamp":1766549304006,"preClose":99.05,"halted":0,"volume":1372630,"delay":0,"floatShares":510476909,"shares":2984000000,"eps":3.043716976630321,"marketStatus":"休市中","change":0.1,"latestTime":"12-24 12:08:24","open":99,"high":101.2,"low":99,"amount":137173915,"amplitude":0.022211,"askPrice":99.15,"askSize":11500,"bidPrice":99.05,"bidSize":7300,"shortable":3,"etf":0,"ttmEps":5.16484520735053,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":7,"adr":0,"listingDate":1544630400000,"exchange":"SEHK","adjPreClose":99.05,"dividendRate":0.014661,"openAndCloseTimeList":[[1766539800000,1766548800000]],"volumeRatio":0.5005282438882277,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603259","market":"SH","secType":"STK","nameCN":"药明康德","latestPrice":92.7,"timestamp":1766732400000,"preClose":91.94,"halted":0,"volume":25704000,"delay":0,"premium":"-3.61"}},"requestUrl":"/m/hq/s/02359","defaultTab":"news","newsList":[{"id":"2593373419","title":"A股回购规模超1400亿元，真金白银护航市场估值修复｜2025中国经济年报","url":"https://stock-news.laohu8.com/highlight/detail?id=2593373419","media":"华夏时报网","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593373419?lang=zh_cn&edition=full","pubTime":"2025-12-23 22:05","pubTimestamp":1766498753,"startTime":"0","endTime":"0","summary":"2025年回购金额排名前十上市公司，数据截至12月23日2025年以来，A股市场在经济复苏与外部环境波动的双重影响下，呈现出阶段性调整与结构性机会并存的格局。Wind数据显示，截至12月23日收盘，今年以来A股市场已有近1500家上市公司实施股份回购，累计回购股份数量超130亿股，累计回购金额突破1400亿元。再贷款首期额度3000亿元，到了2025年5月总额度进一步提升至8000亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223221759a46f4bf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223221759a46f4bf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["601668","LU1993786604.SGD","02880","LU1152091168.USD","000100","000725","03750","600519","01919","002415","BK1610","000425","06936","LU0880133367.SGD","LU1008478684.HKD","LU1152091754.HKD","02359","300750","603259","601919","LU1807302812.USD","601816","LU1960683339.HKD","002714","002352","LU0067412154.USD","BK1116","000333","00300"],"gpt_icon":1},{"id":"2593641143","title":"药明康德12月23日主力净流出772.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2593641143","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593641143?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:15","pubTimestamp":1766477750,"startTime":"0","endTime":"0","summary":"12月23日, 药明康德股价跌2.03%，报收99.05元，成交金额5.0亿元，换手率0.98%，振幅3.66%，量比0.90。药明康德今日主力资金净流出772.9万元，上一交易日主力净流入2002.9万元。该股近5个交易日下跌2.86%，主力资金累计净流入1.3亿元；近20日主力资金累计净流入7.0亿元，其中净流入天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223162042a6c50dad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223162042a6c50dad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","LU0320764599.SGD","BK1576","LU2045819591.USD","LU0052750758.USD","LU1046422090.SGD","LU2125910500.SGD","LU2242644610.SGD","LU0708995583.HKD","BK1141","02359"],"gpt_icon":0},{"id":"2593494070","title":"HTI医药2025年12月第三周周报：行业高景气，持续关注创新药械产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2593494070","media":"海通国际","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593494070?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:07","pubTimestamp":1766477237,"startTime":"0","endTime":"0","summary":"2025年12月第三周A股医药板块表现与大盘相当。2025年12月第三周上证综指上涨0.03%，SW医药生物下跌0.1%，涨跌幅在申万一级行业中排名第19位。截至2025年12月19日，医药板块相对于全部A股的溢价水平目前处于正常水平，当前相对溢价率70.1%。2025年12月第三周美股标普医疗保健精选行业+0.6%，同期标普500+0.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223160731a6c4fe72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223160731a6c4fe72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06078","09939","HK0000500386.USD","02615","BK1574","HK0000252152.HKD","02359","09606","HK0000252160.HKD","01276","01530","01801","01858","BK1161","06160","02487","06990","BK1515","LU2543165471.USD","02269"],"gpt_icon":0},{"id":"2593895934","title":"药明康德：贝莱德H股多头持仓比例增至5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593895934","media":"和讯网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593895934?lang=zh_cn&edition=full","pubTime":"2025-12-22 18:14","pubTimestamp":1766398452,"startTime":"0","endTime":"0","summary":"【12月17日贝莱德增持药明康德H股，持仓比例升至5.10%】12月22日港交所文件披露，贝莱德对药明康德(2359.HK)H股的多头持仓比例，在12月17日出现变动。其持仓比例从4.65%增加至5.10%。本文由 AI 算法生成，仅作参考，不涉投资建议，使用风险自担","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222181751a469fd9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222181751a469fd9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1046422090.SGD","LU2045819591.USD","BK1576","BK1141","02359","LU0708995583.HKD","LU2125910500.SGD","LU2242644610.SGD","LU0320764599.SGD","BK1583","LU0052750758.USD"],"gpt_icon":0},{"id":"2593301489","title":"每日卖空追踪 | 药明康德 12月22日卖空量成交74.09万股，卖空比例为10.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593301489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593301489?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:30","pubTimestamp":1766392230,"startTime":"0","endTime":"0","summary":"药明康德北京时间12月22日，跌2.6%，卖空量成交74.09万股，较上一交易日减少80.86%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163537a6c09c99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163537a6c09c99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320764599.SGD","BK1576","BK1583","BK1141","LU2242644610.SGD","LU0708995583.HKD","LU2125910500.SGD","LU1046422090.SGD","LU2045819591.USD","LU0052750758.USD","02359"],"gpt_icon":0},{"id":"2593657109","title":"医药外包概念股逆市受压 康龙化成(03759)跌4.14% 机构指美生物安全法案对华CXO企业经营影响有限","url":"https://stock-news.laohu8.com/highlight/detail?id=2593657109","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593657109?lang=zh_cn&edition=full","pubTime":"2025-12-22 14:06","pubTimestamp":1766383579,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念股逆市受压，截至发稿，康龙化成 跌4.14%，药明生物跌3.75%，药明康德跌2.89%，昭衍新药跌2.67%，泰格医药跌2.07%，金斯瑞生物科技跌1.36%。招银国际表示，MSCI中国医疗指数2025年初至今累计上涨51.9%，跑赢MSCI中国指数24.3%。近期，医药板块有所回调。政策端方面，《生物安全法案》虽已签署生效，但鉴于其未波及Medicaid和Medicare的采购且对关联方定义明确，以及中国CXO美国行政机构收入占比较小，该机构预计该法案对中国CXO企业实质经营影响有限。","market":"us","thumbnail":"https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/ZDlhMzNiODA0MWQ5OWM0NDQ5YzUxMTZmZWRlMTczNjQ3MzM4NzkwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1972004","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516902.SGD","06127","LU0327786744.USD","LU2125910500.SGD","BK1574","LU0572944931.SGD","BK1141","BK1610","BK1161","HK0000306685.HKD","LU1880383366.USD","LU0708995583.HKD","02269","LU0348825331.USD","BK1583","LU0516422440.USD","BK1589","300759","SG9999002562.SGD","09939","LU0051755006.USD","LU0348735423.USD","159938","LU0823426308.USD","HK0000306701.USD","LU0516423174.USD","LU0819121731.USD","LU0326950275.SGD","02359","HK0000320223.HKD","03759","LU0359201612.USD","LU0516423091.SGD","CXO","LU0140636845.USD","01548","SG9999002463.SGD","BK1576","LU0320764599.SGD","HK0000320264.USD","LU0456846285.SGD","03347","LU2039709279.SGD","LU1046422090.SGD","BK0216","LU0359202008.SGD","LU0417516738.SGD","LU1242518931.SGD","LU1720050803.USD","LU3063872942.SGD"],"gpt_icon":0},{"id":"2593569489","title":"独占无锡A股上市公司回购近半壁江山！药明康德以“高成长+高回报”成投资者回报“压舱石”","url":"https://stock-news.laohu8.com/highlight/detail?id=2593569489","media":"映象网","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593569489?lang=zh_cn&edition=full","pubTime":"2025-12-22 13:50","pubTimestamp":1766382600,"startTime":"0","endTime":"0","summary":"作为无锡头部企业回报投资者的标杆，药明康德以128亿元现金分红总额高居无锡板块首位，是省内鲜有的分红超百亿民营上市企业。与此同时，“十四五”期间药明康德实施股份回购规模达50亿元，占同期无锡A股企业回购总额近半壁江山。截至三季度末，药明康德持续经营业务在手订单金额已逼近600亿元，同比增长超40%，全年收入指引也再度上调。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222135021a6bffc53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222135021a6bffc53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320764599.SGD","BK1576","LU2242644610.SGD","LU1046422090.SGD","LU0708995583.HKD","LU2125910500.SGD","LU0052750758.USD","LU2045819591.USD","BK1141","02359","BK1583"],"gpt_icon":0},{"id":"2593489580","title":"药明康德盘中异动 下午盘急速下挫3.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593489580","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593489580?lang=zh_cn&edition=full","pubTime":"2025-12-22 13:27","pubTimestamp":1766381229,"startTime":"0","endTime":"0","summary":"2025年12月22日下午盘13时27分，药明康德股票出现波动，股价大幅跳水3.08%。截至发稿，该股报100.600港元/股，成交量347.355万股，换手率0.68%，振幅3.28%。资金方面，该股资金流入1.82193亿港元，流出1.48789亿港元。药明康德股票所在的生物技术行业中，整体跌幅为1.16%。其相关个股中，北海康成-B、中生北控生物科技、迈博药业-B涨幅较大，振幅较大的相关个股有华昊中天医药-B、华生物-B、加科思-B，振幅分别为23.40%、16.23%、14.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222132710a6bfeb19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222132710a6bfeb19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2125910500.SGD","LU0052750758.USD","LU2242644610.SGD","BK1576","LU0320764599.SGD","LU1046422090.SGD","BK1583","LU0708995583.HKD","BK1141","LU2045819591.USD","02359"],"gpt_icon":0},{"id":"2593489557","title":"医药生物行业动态研究：CRO需求回暖 实验猴供给紧张涨价","url":"https://stock-news.laohu8.com/highlight/detail?id=2593489557","media":"国海证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593489557?lang=zh_cn&edition=full","pubTime":"2025-12-22 00:00","pubTimestamp":1766332800,"startTime":"0","endTime":"0","summary":"临床前CRO 客户需求回暖，上游实验猴供给端紧张。本周沪深300 下跌0.28%，医药生物下跌0.14%，处于31 个一级子行业第22 位，医药子板块中，医药商业板块本周涨幅较大，化学制药、生物制品、医疗器械、医药商业、中药、医疗服务本周涨跌幅分别为-1.74%、-0.67%、1.16%、4.94%、0.17%、0.55%。综合考虑上述因素，我们维持医药生物行业“中性”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222162130a6c08b1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222162130a6c08b1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02359","BK1161","LU2045819591.USD","09939","BK1576","LU0052750758.USD","LU2242644610.SGD","BK1515","LU0708995583.HKD","LU1046422090.SGD","LU2125910500.SGD","BK1574","LU0320764599.SGD","BK1141","BK1583"],"gpt_icon":0},{"id":"2593489555","title":"医药行业周报：本周申万医药生物指数下跌0.1% 关注国内药企出海动态","url":"https://stock-news.laohu8.com/highlight/detail?id=2593489555","media":"申万宏源研究","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593489555?lang=zh_cn&edition=full","pubTime":"2025-12-22 00:00","pubTimestamp":1766332800,"startTime":"0","endTime":"0","summary":"本期投资提示：市场表现：本周申万医药生物指数下跌0.1%，同期上证指数上涨0.03%，万得全A下跌0.5%。本周医药生物指数在31 个申万一级子行业中表现排名第22。12 月18 日，诺和诺德宣布向FDA 递交CagriSema 上市申请，这是全球首款GLP-1+Amylin 联合疗法。全球首个用于治疗成瘾类精神疾病的侵入式脑机接口获批，福瑞医科及百普赛斯拟赴港上市。12 月16 日，恒瑞医药持股公司Kailera 启动HRS-9531 三项全球III 期临床，覆盖肥胖合并及不合并糖尿病适应症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222182625a6c10bdf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222182625a6c10bdf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1046422090.SGD","LU2242644610.SGD","BK1576","02359","LU0052750758.USD","BK1583","LU2045819591.USD","LU0708995583.HKD","LU0320764599.SGD","06127","BK1141","LU2125910500.SGD"],"gpt_icon":0},{"id":"2592685091","title":"12月19日药明康德现10笔大宗交易 机构净买入2亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592685091","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592685091?lang=zh_cn&edition=full","pubTime":"2025-12-19 17:54","pubTimestamp":1766138065,"startTime":"0","endTime":"0","summary":"证券之星消息，12月19日药明康德发生大宗交易，交易数据如下：近三个月该股共发生42笔大宗交易，合计成交19.75万手，折价成交37笔。该股近期无解禁股上市。截至2025年12月19日收盘，药明康德报收于92.47元，上涨2.08%，换手率1.88%，成交量46.38万手，成交额43.16亿元。该股近半年内有股东持股变动，合计净减持4133.67万股，股东增减持明细如下表：该股最近90天内共有22家机构给出评级，买入评级21家，增持评级1家；过去90天内机构目标均价为129.36。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/19/20251219396505.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/19/20251219396505.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251219/31878013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU1997245094.SGD","BK1141","LU0320764599.SGD","LU1808992512.USD","LU1969619763.USD","LU2125910500.SGD","LU1997245177.USD","02359","LU0052750758.USD","LU0456842615.SGD","LU1997244956.HKD","LU1046422090.SGD","BK0216","LU2488822045.USD","LU2495084118.USD","BK1576","LU1934453819.USD","BK1583","LU0708995583.HKD","LU2328871848.SGD","603259","LU2045819591.USD","LU2242644610.SGD","LU1979443071.USD"],"gpt_icon":0},{"id":"2592415986","title":"创新药板块观察：沉寂后的“大招”，估值修复行情启动？","url":"https://stock-news.laohu8.com/highlight/detail?id=2592415986","media":"投资者研究中心","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592415986?lang=zh_cn&edition=full","pubTime":"2025-12-19 15:08","pubTimestamp":1766128104,"startTime":"0","endTime":"0","summary":"12月19日，A股创新药板块迎来久违的集体反弹。不过，也应清醒认识到，创新药板块本身具有高波动性，受研发进展、临床数据、政策节奏、市场竞争等多重因素影响，单日大涨并不等同于趋势性反转，更多应视为政策驱动下的估值修复启动信号。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219152804a6b5f938&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219152804a6b5f938&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0708995583.HKD","LU0052750758.USD","BK1576","BK1574","LU0320764599.SGD","LU1046422090.SGD","LU2125910500.SGD","BK1161","LU2242644610.SGD","LU2045819591.USD","BK1583","03347","02359","BK1141","06978"],"gpt_icon":0},{"id":"2592159839","title":"FDA质量警报频响 药明康德如何成为“零缺陷”通关达人？","url":"https://stock-news.laohu8.com/highlight/detail?id=2592159839","media":"宿迁网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592159839?lang=zh_cn&edition=full","pubTime":"2025-12-19 10:28","pubTimestamp":1766111305,"startTime":"0","endTime":"0","summary":"2025年3月，药明康德常州与泰兴两个原料药基地相继以零缺陷通过FDA检查，未收到任何“483表格”，再次印证了其质量体系的可靠性。除了严控质量，药明康德的高效执行也备受认可。药明康德凭借其全球化CRDMO网络启动跨时区协作，最终准时交付高质量报告，成为推动客户达成交易的重要助力。净利润增速显著高于营收增速，充分体现了药明康德业务结构优化与运营效率提升已转化为实际盈利增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219130236a6b58371&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219130236a6b58371&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1576","LU0320764599.SGD","LU2125910500.SGD","BK1141","LU2242644610.SGD","LU1046422090.SGD","LU2045819591.USD","02359","LU0708995583.HKD","BK1583","LU0052750758.USD"],"gpt_icon":0},{"id":"2592139047","title":"医药外包概念普遍走高 药明生物(02269)涨6.11% 机构看好看好CXO在业绩和估值端迎来双重修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139047","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592139047?lang=zh_cn&edition=full","pubTime":"2025-12-19 10:26","pubTimestamp":1766111188,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念普遍走高，药明生物 涨6.11%，凯莱英升5.52%，康龙化成升4.69%，泰格医药升3.8%，维亚生物升3.72%，药明康德涨3.32%。世纪证券此前研报指出，本周NDAA法案落地，地缘风险趋于缓和。CXO业绩和新增订单开始好转，本周市场开始关注临床前安评试验资产食蟹猴。该机构认为CXO作为创新药产业链上游，行业经历过完整周期，有望受益于国产创新药竞争力提升带来的景气度回升，看好CXO在业绩和估值端迎来双重修复。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"66afc1ba6d0078bbc724c4259409298b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971871","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02359","LU0051755006.USD","LU2045819591.USD","LU0417516902.SGD","LU2125910500.SGD","LU0348735423.USD","LU0348825331.USD","LU1794554557.SGD","LU0140636845.USD","LU0456827905.SGD","LU0181495838.USD","BK1589","LU1720050803.USD","LU0819121731.USD","BK1191","LU0516422366.SGD","LU0359201612.USD","LU0320764599.SGD","SG9999002562.SGD","BK1574","BK1610","06821","LU0052750758.USD","BK1521","CXO","LU2242644610.SGD","LU0039217434.USD","LU0516423091.SGD","LU0823426480.USD","LU0516423174.USD","LU1880383366.USD","LU0516422952.EUR","LU0979878070.USD","BK1576","159938","SG9999002463.SGD","02269","BK1583","03759","09939","03347","LU0516422440.USD","LU1046422090.SGD","IE00B0JY6N72.USD","LU1242518931.SGD","LU3063872942.SGD","LU0043850808.USD","01873","LU0708995583.HKD"],"gpt_icon":0},{"id":"2592890154","title":"12月8日增减持汇总：西藏药业等3股增持 药明康德等11股减持（表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2592890154","media":"新浪证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592890154?lang=zh_cn&edition=full","pubTime":"2025-12-18 21:59","pubTimestamp":1766066340,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 　　据统计，12月18日，盘后大中矿业、四川路桥、西藏药业披露增持情况。包括立达信、药明康德、飞龙股份、瑞晨环保、蠡湖股份、君实生物、奕东电子、华海诚科、博硕科技、安联锐视、大中矿业在内的11家A股上市公司披露减持情况。\n\n\n\n新浪声明：此消息系转载自新浪合作媒体，新浪网登载此文出于传递更多信息之目的，并不意味着赞同其观点或证实其描述。文章内容仅供参考，不构成投资建议。投资者据此操作，风险自担。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2025-12-18/doc-inhcfvmc8319448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1979443071.USD","LU2495084118.USD","BK1583","LU1997244956.HKD","BK1141","LU2328871848.SGD","LU1046422090.SGD","LU2045819591.USD","BK0216","LU0052750758.USD","600211","LU1997245177.USD","LU1934453819.USD","LU2488822045.USD","BK1576","LU1808992512.USD","LU2125910500.SGD","LU1997245094.SGD","02359","LU2242644610.SGD","LU0708995583.HKD","BK0033","BK0239","603259","LU0320764599.SGD","LU0456842615.SGD","LU1969619763.USD"],"gpt_icon":0},{"id":"2592710089","title":"12月18日药明康德现10笔大宗交易 机构净买入2.51亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592710089","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592710089?lang=zh_cn&edition=full","pubTime":"2025-12-18 17:52","pubTimestamp":1766051523,"startTime":"0","endTime":"0","summary":"证券之星消息，12月18日药明康德发生大宗交易，交易数据如下：近三个月该股共发生32笔大宗交易，合计成交16.75万手，折价成交27笔。该股近期无解禁股上市。截至2025年12月18日收盘，药明康德报收于90.59元，上涨0.0%，换手率1.16%，成交量28.65万手，成交额26.09亿元。该股近半年内有股东持股变动，合计净减持1182.79万股，股东增减持明细如下表：该股最近90天内共有22家机构给出评级，买入评级21家，增持评级1家；过去90天内机构目标均价为129.36。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800027367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0708995583.HKD","BK1576","LU1979443071.USD","LU1808992512.USD","603259","LU1934453819.USD","LU1997245177.USD","LU1997245094.SGD","BK0216","BK1583","LU2495084118.USD","LU1046422090.SGD","LU2045819591.USD","02359","LU1997244956.HKD","LU2488822045.USD","LU1969619763.USD","LU0320764599.SGD","LU0052750758.USD","LU2242644610.SGD","LU2125910500.SGD","BK1141","LU0456842615.SGD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2592813972","title":"A股今日共78只个股发生大宗交易，总成交37.55亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592813972","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592813972?lang=zh_cn&edition=full","pubTime":"2025-12-18 17:41","pubTimestamp":1766050860,"startTime":"0","endTime":"0","summary":"Wind数据显示，今日A股共78只个股发生大宗交易，总成交37.55亿元，其中民生银行、药明康德、露笑科技成交额居前，成交额依次为21.49亿元、4.3亿元、1.19亿元。成交价方面，共8只股票平价成交，3只股票溢价成交，67只股票折价成交；中航光电、中科曙光、豪威集团溢价率居前，溢价率依次为8.04%、7.92%、2.07%；聚星科技、蒙泰高新、汉仪股份折价率居前，折价率依次为29.04%、22.41%、21.22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218174116a6b1ffb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218174116a6b1ffb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320764599.SGD","BK1560","01988","LU0052750758.USD","LU1046422090.SGD","LU2045819591.USD","BK1231","BK1583","LU2125910500.SGD","BK1576","LU2242644610.SGD","LU0708995583.HKD","02359","BK1141"],"gpt_icon":0},{"id":"2592197233","title":"每日卖空追踪 | 药明康德 12月18日卖空量成交28.96万股，卖空比例为10.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592197233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592197233?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:30","pubTimestamp":1766046628,"startTime":"0","endTime":"0","summary":"药明康德北京时间12月18日，涨0.99%，卖空量成交28.96万股，较上一交易日减少60.5%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163442a45aa34f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163442a45aa34f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1046422090.SGD","LU2125910500.SGD","LU2242644610.SGD","BK1576","02359","BK1141","LU0708995583.HKD","LU0320764599.SGD","BK1583","LU2045819591.USD","LU0052750758.USD"],"gpt_icon":0},{"id":"2592513924","title":"创新药概念逆市上扬 石药集团(01093)午后升幅扩至近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592513924","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592513924?lang=zh_cn&edition=full","pubTime":"2025-12-18 13:21","pubTimestamp":1766035316,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念逆市上扬，石药集团 升5.98%，药明生物升1.97%，药明合联升1.56%，先声药业升1.51%，药明康德升1.28%。开源证券指出，当前纳入医保+商保的创新药大多处于未放量以及低基数阶段，随着医保支持创新药的政策红利持续释放，我们认为纳入双目录的创新药收入有望快速提升，患者有望持续受益，同时相关创新药企也随之迎来弹性增长。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971799","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320764599.SGD","LU0051755006.USD","LU1008478684.HKD","02269","IE00BZ08YT58.USD","LU0052750758.USD","LU1328277881.USD","01093","LU0456827905.SGD","LU1807302812.USD","LU0307460666.USD","LU0501845795.SGD","LU0348825331.USD","LU0588546209.SGD","SG9999002562.SGD","LU1226287792.SGD","SG9999002463.SGD","IE00B543WZ88.USD","LU1152091754.HKD","LU3063872942.SGD","LU0856984785.SGD","02096","BK1583","06978","LU1688375341.USD","02359","LU0140636845.USD","BK1515","BK1610","159992","IE00BZ08YR35.GBP","LU1242518931.SGD","LU0315179316.USD","LU1813983027.USD","LU0572944931.SGD","LU1242518857.USD","IE00B5MMRT66.SGD","LU1226287875.USD","02268","IE00B031HY20.USD","LU0039217434.USD","BK1574","LU0181495838.USD","LU0348735423.USD","LU1794554557.SGD","IE00BZ08YS42.EUR","LU1046422090.SGD","IE0008369823.USD","BK1589","BK1191"],"gpt_icon":0},{"id":"2592171991","title":"摩根大通增持药明康德(02359)约87.21万股 每股作价约106.32港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592171991","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592171991?lang=zh_cn&edition=full","pubTime":"2025-12-17 19:15","pubTimestamp":1765970135,"startTime":"0","endTime":"0","summary":"12月11日，摩根大通增持药明康德(02359)87.2123万股，每股作价106.3228港元，总金额约为9272.66万港元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20251217/20251217190717_20223.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251217/20251217190717_20223.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382712.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0234572021.USD","IE00BZ1G4Q59.USD","LU0868494708.USD","IE00B775SV38.USD","02359","LU1808992512.USD","LU0203345920.USD","BK1576","LU1084165304.USD","BK4504","LU0238689110.USD","LU2125910500.SGD","LU1064131342.USD","LU0170899867.USD","LU0496365809.HKD","LU1629891620.HKD","LU2237443549.SGD","IE00BJTD4N35.SGD","LU1267930490.SGD","LU2430703178.SGD","LU0211331839.USD","LU0964807845.USD","LU2430703251.USD","SG9999002224.SGD","LU2242644610.SGD","IE00BJTD4V19.USD","LU0211327993.USD","LU1116320901.HKD","IE00BKDWB100.SGD","LU1997244956.HKD","IE00B1BXHZ80.USD","LU0323591593.USD","IE00BYXW3230.USD","LU0417517546.SGD","LU1046422090.SGD","LU2357305700.SGD","LU0251132253.USD","LU2417539215.USD","LU0310799852.SGD","LU1145028129.USD","603259","LU2236285917.USD","IE00BKVL7J92.USD","LU1974910355.USD","LU2237443978.SGD","LU1914381329.SGD","LU1244550221.USD","LU2237443465.HKD","LU0070302665.USD","IE00BFXG1179.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.wuxiapptec.com.cn","stockEarnings":[{"period":"1week","weight":-0.0212},{"period":"1month","weight":-0.0708},{"period":"3month","weight":-0.1092},{"period":"6month","weight":0.3082},{"period":"1year","weight":0.8283},{"period":"ytd","weight":0.8008}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0251},{"period":"6month","weight":0.0632},{"period":"1year","weight":0.2846},{"period":"ytd","weight":0.2871}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"无锡药明康德新药开发股份有限公司是一家主要从事新药研发和生产服务业务的中国公司。该公司主要通过六个分部开展业务。化学业务分部主要从事提供新药研究、开发与生产服务。测试业务分部主要从事提供药品、医疗器械、体外诊断试剂服务。生物学业务分部主要从事提供药物发现及研究服务。高端治疗合同测试、研发与生产（CTDMO）业务分部主要从事为客户提供医疗产品工艺开发、生产和测试一体化服务。国内新药研发服务部分部主要从事为客户提供一体化新药研发服务。其他业务分部主要从事行政服务、销售原材料和销售废料业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.012449},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.006618},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.010471},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.015053},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.001001},{"month":6,"riseRate":0.714286,"avgChangeRate":0.076679},{"month":7,"riseRate":0.714286,"avgChangeRate":0.099103},{"month":8,"riseRate":0.571429,"avgChangeRate":0.042308},{"month":9,"riseRate":0.571429,"avgChangeRate":0.088071},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.002335},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.002939},{"month":12,"riseRate":0.571429,"avgChangeRate":0.038873}],"exchange":"SEHK","name":"药明康德","nameEN":"WUXI APPTEC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明康德,02359,药明康德股票,药明康德股票老虎,药明康德股票老虎国际,药明康德行情,药明康德股票行情,药明康德股价,药明康德股市,药明康德股票价格,药明康德股票交易,药明康德股票购买,药明康德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明康德(02359)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明康德(02359)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}